A lawsuit filed against GoodRx earlier this year alleges that the company is orchestrating an illegal price-fixing scheme with major pharmacy benefit managers that artificially suppresses reimbursement rates paid to independent pharmacies for generic drugs.

The class action lawsuit alleges that large pharmacies, like CVS, can weather lower reimbursements, but independent pharmacies cannot. The alleged scheme aims to drive smaller pharmacies, which compete with larger PBM affiliates, out of the market, and it hurts their customers. 

One local pharmacy CBS News Detroit talked with, which was involved in the lead-up to the lawsuit and may be part of the settlement process, claimed that it's become more difficult to operate an independent pharmacy.

"This movement isn't one lawsuit, it's not two lawsuits. It's thousands of pharmacies and thousands of pharmacists that can't take it anymore," the pharmacy owner said. "Knowing that the PBMs (pharmacy benefit managers) are profiting off of not only the patient and the pharmacy, but the general public alike. We thought this was a great opportunity to step up for our patients and the community at large and say enough is enough."

Faye Nemer, CEO of the MENA American Chamber of Commerce, noted that there are currently two pharmacies closing per month in Michigan.

"Obviously, this is a cause for concern," Nemer said.

Eric Roath, with the Michigan Pharmacists Association, said, "Patients are paying more at the prescription counter than they would have had the claims been correctly paid by the PBMs in the first place."

CBS News Detroit contacted GoodRx on Tuesday for comment and is waiting to hear back.